Drug Type Small molecule drug |
Synonyms Digoxin/furosemide, ICVT, CLS-003 |
Target |
Mechanism NKCC2 inhibitors(Sodium-(potassium)-chloride cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC41H64O14 |
InChIKeyLTMHDMANZUZIPE-PUGKRICDSA-N |
CAS Registry20830-75-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Actinic Keratosis | Phase 2 | NL | - | |
Actinic Keratosis | Phase 2 | - | - | |
Condylomata Acuminata | Phase 2 | NL | - | |
Condylomata Acuminata | Phase 2 | - | - | |
Human Papillomavirus Infection | Phase 2 | GB | - | |
Keratoconjunctivitis, Infectious | Phase 2 | AT | - | - |
Keratoconjunctivitis, Infectious | Phase 2 | SK | - | - |
Vulvar intraepithelial neoplasia | Phase 2 | NL | - | |
Vulvar Neoplasms | Phase 2 | - | - | |
Herpes Simplex | Preclinical | US | - |